Drugs / COVID-19 Vaccine (Vero Cell), Inactivated
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT05150496 | Dec 2022 → Jan 2023 | COVID-19 | Sinovac Research and Development Co., Ltd. | Suspended | No outcome recorded |
| Phase 2 | NCT05254236 | Feb → Mar 2022 | COVID-19 | Sinovac Research and Development Co., Ltd. | Withdrawn | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT05398926 | Dec 2021 → Jun 2022 | COVID-19 | Sinovac Life Sciences Co., Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT05165966 | Oct 2021 → Apr 2022 | COVID-19 | Sinovac Life Sciences Co., Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT04863638 | Apr → Dec 2021 | COVID-19 | China National Biotec Group Company Limited | Unknown | No outcome recorded |
| Comparator or background therapy9 trials | ||||||
| Phase 1 | NCT06113744 Comparator | Mar → Jun 2023 | COVID-19 | CNBG-Virogin Biotech (Shanghai) Ltd. | Unknown | No outcome recorded |
| Phase 2 | NCT06113731 Comparator | Jul → Oct 2023 | COVID-19 | CNBG-Virogin Biotech (Shanghai) Ltd. | Unknown | No outcome recorded |
| Phase 2 | NCT05465902 Comparator | Jul 2023 → Nov 2024 | COVID-19 | WestVac Biopharma Co., Ltd. | Withdrawn | No outcome recorded |
| Phase 2 | NCT05463354 Comparator | Jul → Aug 2022 | COVID-19 | WestVac Biopharma Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT05323435 Comparator | May → Jul 2022 | COVID-19 | Jiangsu Rec-Biotechnology Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT05433272 Comparator | Aug → Sep 2023 | COVID-19 | Sinovac Biotech (Colombia) S.A.S. | Unknown | No outcome recorded |
| Phase 3 | NCT05382871 Comparator | May 2022 → Jul 2023 | COVID-19 | China National Biotec Group Company Limited | Unknown | No outcome recorded |
| Phase 3 | NCT05374954 Comparator | May → Sep 2022 | COVID-19 | China National Biotec Group Company Limited | Unknown | No outcome recorded |
| — | NCT06381843 Comparator | Aug 2022 → Mar 2023 | COVID-19 | WestVac Biopharma Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 15 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVID-19 vaccine (Vero cell), Inactivated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05165966 ↗ |
| Known as | COVILO | “Study-1 involved subjects were randomized (1:1:1) to receive 20 μg ReCOV, 40 μg ReCOV, or an inactivated vaccine (COVILO®) in the United Arab Emirates.” PMID 38529685 ↗ Apr 2024 |
| Modality | Vaccine | “COVID-19 Vaccine (Vero Cell), Inactivated” NCT04863638 ↗ |
| Route | Intramuscular | “intramuscular injection in the deltoid muscle” NCT05382871 ↗ |